Skip to content

Clinical trials

Phase 3 Heart Failure trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Japan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20142
20174
20182
20194
20202
20232
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting8
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
AstraZeneca4
Novartis Pharmaceuticals3
Otsuka Pharmaceutical Co., Ltd.3
Novo Nordisk A/S2
Amgen1
Bayer1
Boston Scientific Corporation1
CSL Behring1
Colorado Prevention Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure26
Coronary Artery Disease2
Obesity2
Stroke2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Bundle-Branch Block1
Cardiovascular Diseases1
Heart Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.